Chimerix (United States)

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

Per Ljungman, Michael Boeckh, Hans H. Hirsch et al. · Clinical Infectious Diseases · 2016 · 916 citations · Full text

Viral Diagnostics, Immunology, Transplantation Medicine +18

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Francisco M. Marty, Drew J. Winston, Scott D. Rowley et al. · New England Journal of Medicine · 2013 · 370 citations · Full text

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Kris V. Kowdley, Eric Lawitz, Israel Crespo et al. · The Lancet · 2013 · 296 citations

Hepatitis C, Multicentre Phase 2, Viral Hepatitis +8

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

Thomas H. Price, Michael Boeckh, Ryan W. Harrison et al. · Blood · 2015 · 240 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Francisco M. Marty, Drew J. Winston, Roy F. Chemaly et al. · Biology of Blood and Marrow Transplantation · 2018 · 210 citations · Full text